Literature DB >> 7981073

Expression of interleukin 10 in human melanoma.

S Krüger-Krasagakes1, K Krasagakis, C Garbe, E Schmitt, C Hüls, T Blankenstein, T Diamantstein.   

Abstract

The expression of interleukin 10 (IL-10) mRNA in human malignant melanoma was investigated by reverse transcriptase polymerase chain reaction analysis. Selective expression of IL-10 mRNA in tissues of primary melanomas and melanoma metastases was found in comparison with normal skin. In addition, strong expression of IL-10 mRNA and of biologically active IL-10 was detected in 3 out of 13 melanoma cell lines. Normal melanocytes consistently expressed low levels of IL-10 mRNA but did not produce detectable IL-10 protein, nor did keratinocytes or fibroblasts. The production of biologically active IL-10 by melanoma cell lines suggests that IL-10 mRNA in melanoma lesions may derive at least in part from the tumour cells themselves. Tumour-infiltrating cells, however, could also be a source of IL-10 in melanoma tissues. The presence of IL-10 in melanoma lesions may contribute to the postulated 'paralysis' of an anti-melanoma immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981073      PMCID: PMC2033698          DOI: 10.1038/bjc.1994.469

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

Review 1.  Lymphokine gene therapy for cancer.

Authors:  S J Russell
Journal:  Immunol Today       Date:  1990-06

2.  Lymphocytic reaction around primary and metastatic melanomas.

Authors:  H M Payan; E F Gilbert; W H Jacobs
Journal:  South Med J       Date:  1970-11       Impact factor: 0.954

3.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Authors:  D H Hsu; R de Waal Malefyt; D F Fiorentino; M N Dang; P Vieira; J de Vries; H Spits; T R Mosmann; K W Moore
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

4.  Identification and induction of keratinocyte-derived IL-10.

Authors:  A H Enk; S I Katz
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

5.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

Authors:  P Vieira; R de Waal-Malefyt; M N Dang; K E Johnson; R Kastelein; D F Fiorentino; J E deVries; M G Roncarolo; T R Mosmann; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

7.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.

Authors:  P Ralph; I Nakoinz; A Sampson-Johannes; S Fong; D Lowe; H Y Min; L Lin
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

8.  IL-10 inhibits human T cell proliferation and IL-2 production.

Authors:  K Taga; G Tosato
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

9.  A sensitive and specific bioassay for the detection of human interleukin-10.

Authors:  J F Schlaak; E Schmitt; C Hüls; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Immunol Methods       Date:  1994-01-12       Impact factor: 2.303

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

2.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

Review 3.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

4.  A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens.

Authors:  M Nakamura; M Katano; K Fujimoto; T Morisaki
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

5.  Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.

Authors:  N Jacobs; S L Giannini; J Doyen; A Baptista; M Moutschen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  Ascites IL-10 Promotes Ovarian Cancer Cell Migration.

Authors:  Denis Lane; Isabelle Matte; Perrine Garde-Granger; Paul Bessette; Alain Piché
Journal:  Cancer Microenviron       Date:  2018-07-23

7.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.

Authors:  Luis Vence; A Karolina Palucka; Joseph W Fay; Tomoki Ito; Yong-Jun Liu; Jacques Banchereau; Hideki Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

9.  Comparative cytokine gene expression: regulation and release by human mast cells.

Authors:  A Möller; B M Henz; A Grützkau; U Lippert; Y Aragane; T Schwarz; S Krüger-Krasagakes
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

Review 10.  Mobilizing the low-avidity T cell repertoire to kill tumors.

Authors:  Rachel H McMahan; Jill E Slansky
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.